全部

1·Conclusion Metadoxine is effective and safe in treatment of alcoholic liver disease.

结论美他多辛片可安全、有效地治疗酒精性肝病。

2·Methods rat model of alcoholic liver disease were established by alcohol administration.

方法酒精灌胃法制备大鼠酒精性肝病模型。

3·ObjectiveTo evaluate the efficacy and safety of Metadoxine in treatment of alcoholic liver disease.

目的评价美他多辛片治疗酒精性肝病的临床疗效和安全性。

4·Objective To search a simple and reliable method for establishing an alcoholic liver disease model in rats.

目的寻找一种简单可靠的方法制作大鼠慢性酒精性肝病模型。

5·Objective: To observe the therapeutic effects and the reliability of Canle on alcoholic liver disease (ALD).

目的：观察甘乐对酒精性肝病的疗效和安全性。

6·Objective To evaluate the efficacy and safety of Capsule metadoxine in the treatment of alcoholic liver disease.

目的观察美他多辛胶囊治疗酒精性肝病的临床疗效和安全性。

7·Objective To explore the effect of cyclooxygenase 2 (COX-2) in the pathogenesis of alcoholic liver disease (ALD).

目的探讨环氧合酶2 (COX - 2)在酒精性肝病(ALD)发病机制中的作用。

8·Objective To study the relation of serum leptin and liver function in patients with alcoholic liver disease (ALD).

目的探讨瘦素在酒精性肝病(ALD)及不同阶段中的变化规律及其与肝功能受损的关系。

9·Objective: To explore the effect and safety of tetramethylpyrazine combined glutathione on alcoholic liver disease.

目的：探讨川芎嗪联合谷胱甘肽对酒精性肝病的疗效及安全性。

10·Conclusion: In rats with alcoholic liver disease, BFGF is highly expressed, and KXI could decrease BFGF expression.

结论：在酒精性肝病BFGF的表达增强，抗纤复方I号能降低其表达。